Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi(University of Pennsylvania), Michael J. Hogan(University of Pennsylvania), Rebecca S. Pelc(National Institutes of Health), Hiromi Muramatsu(University of Pennsylvania), Hanné Andersen(Bioqual), Christina R. DeMaso(National Institutes of Health), Kimberly A. Dowd(National Institute of Allergy and Infectious Diseases), Laura L. Sutherland(Duke University), Richard M. Scearce(Duke University), Robert Parks(Duke University), Wendeline Wagner(Bioqual), Alex Granados(Bioqual), Jack Greenhouse(Bioqual), Michelle Walker(Bioqual), Elinor Willis(University of Pennsylvania), Jae-Sung Yu(Duke University), Charles E. McGee(Duke University), Gregory D. Sempowski(Duke University), Barbara L. Mui(Acuitas Therapeutics (Canada)), Ying K. Tam(Acuitas Therapeutics (Canada)), Yan-Jang S. Huang(Kansas State University), Dana L. Vanlandingham(Kansas State University), Veronica M. Holmes(University of Pennsylvania), Harikrishnan Balachandran(Beth Israel Deaconess Medical Center), Sujata Sahu(Beth Israel Deaconess Medical Center), Michelle A. Lifton(Beth Israel Deaconess Medical Center), Stephen Higgs(Kansas State University), Scott E. Hensley(University of Pennsylvania), Thomas D. Madden(Acuitas Therapeutics (Canada)), Michael J. Hope(Acuitas Therapeutics (Canada)), Katalin Karikó(BioNTech (Germany)), Sampa Santra(Beth Israel Deaconess Medical Center), Barney S. Graham(National Institutes of Health), Mark G. Lewis(Bioqual), Theodore C. Pierson(National Institutes of Health), Barton F. Haynes(Duke University), Drew Weissman(University of Pennsylvania)
Cited by 884Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis